What Exactly Is Platelet-Rich Plasma (PRP), and Why Is It Popular for Treating Hair Loss?

Hair loss is one of the most visible and emotionally charged changes that people experience over time. From medical to cosmetic contexts, the desire to understand and treat it has led to a wide range of therapies. Among them, platelet-rich plasma (PRP) therapy has attracted considerable attention.

But what exactly is platelet-rich plasma, how does it work, and what does the scientific evidence really say about its effectiveness?

Platelets are small cellular fragments circulating in our blood, crucial for wound healing and tissue repair. When an injury occurs, they gather at the damaged site and release proteins known as growth factors—biological molecules that trigger cell division, angiogenesis (formation of new blood vessels), and tissue regeneration. In PRP therapy, this natural healing mechanism is concentrated and redirected toward the scalp.

The procedure begins with drawing a small quantity of the patient’s own blood. This blood is then placed in a centrifuge—a machine that spins it rapidly—to separate its components. The resulting plasma layer, rich in platelets, is collected and injected into areas of the scalp affected by thinning or miniaturized hair follicles. The expectation is that this infusion of growth factors can reactivate dormant follicles and improve hair shaft thickness. The concept seems intuitively appealing, but how solid is the evidence behind it?

Why PRP Became a Trend in Hair Restoration

PRP therapy gained traction for several reasons. First, it uses the patient’s own blood, which clinics present as a natural option. Second, it is minimally invasive and usually needs little recovery time. Finally, it aligns with a broader trend in regenerative medicine: stimulating the body’s own capacity for healing rather than introducing synthetic compounds. However, popularity is not synonymous with proof. When analyzing PRP critically, it is essential to ask: do clinical trials confirm these expectations?

What the Research Really Shows

Scientific studies over the past decade have explored PRP’s potential, but the findings vary due to differences in methods, preparation techniques, and patient populations.

In 2015, Gentile and colleagues in Italy ran a randomized, evaluator-blinded, placebo-controlled half-head trial in men with pattern hair loss (23 enrolled, 3 excluded). PRP was injected on one half of the scalp and placebo on the other, in three sessions 30 days apart. After the third session, the authors reported a mean increase of 33.6 hairs in the target area and 45.9 hairs per cm² in total hair density compared with baseline; the abstract does not give the difference from the placebo side. Four patients had progressive hair loss again after 12 months and were re-treated (Gentile et al., 2015).

Alves and Grimalt (2016) ran a randomized, placebo-controlled, double-blind half-head study in 25 patients with androgenetic alopecia, with three PRP sessions one month apart. Six months after the first session, hair density was higher on the PRP side than on the placebo side.

A 2017 meta-analysis by Gupta and Carviel found 13 studies but could pool data from only four trials (60 participants). It described PRP as an off-label treatment and the evidence as preliminary.

A 2023 meta-analysis of 9 randomized trials (238 patients) found higher hair density with PRP than with placebo at 3 and 6 months, but no significant difference from placebo in hair count or hair thickness (Zhang et al., 2023). Most trials are small and short, and PRP preparation methods differ widely, which makes results hard to compare.

Risks and Who Should Not Have PRP

PRP for hair loss is off-label. The devices used to prepare PRP are FDA-cleared for processing blood, but no PRP product is FDA-approved to treat hair loss (Gupta & Carviel, 2017; Paichitrojjana & Paichitrojjana, 2022). Reported side effects are usually mild and temporary: pain during the injections, mild headache, itching, redness and swelling of the treated area (Paichitrojjana & Paichitrojjana, 2022). The same review lists platelet disorders, a very low platelet count and infection at the injection site as reasons not to have PRP. Anyone taking blood-thinning (anticoagulant or antiplatelet) medicines or anti-inflammatory painkillers should tell the clinician before treatment, because these affect bleeding and platelet function; never stop a prescribed blood thinner without advice from the prescribing doctor.

The Mechanism: How PRP Might Influence Hair Growth

PRP’s biological action is attributed to its concentration of growth factors, such as platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF).

In laboratory and small tissue studies, these molecules can stimulate follicle stem cells and blood-vessel growth around the follicular bulb, which might improve nutrient and oxygen supply. In theory, this environment favors the transition of follicles from the resting (telogen) phase to the active (anagen) phase of growth.

However, this mechanism is still largely theoretical. The degree of platelet concentration, centrifugation speed, and frequency of injections significantly influence the final composition of the PRP. Inconsistent methods between clinics mean that two treatments labeled “PRP” can differ dramatically in potency and outcome. Without standardized preparation protocols, reproducibility remains one of PRP’s greatest challenges.

The Limits of PRP and the Future of Research

PRP is not a cure for baldness. It is generally expected to work best in early or moderate hair loss, where follicles are still present but weakened, and is not expected to help where follicles have already been lost; trials have not tested this directly. Moreover, the treatment’s duration of efficacy remains uncertain, often requiring multiple sessions and periodic maintenance.

**Some recent investigations have begun combining PRP with other interventions **—such as microneedling or low-level laser therapy—to enhance the penetration and biological activation of growth factors. These combinations have been tested only in small studies, and larger, long-term studies are needed.

What We Should Really Take Away

PRP embodies a compelling idea: using our own biology to counteract the biological process of hair thinning. However, it remains a developing field where the enthusiasm often surpasses the scientific consensus. Patients should view PRP as an experimental therapy with potential benefits, but also with clear limitations and inconsistencies in evidence. Understanding these nuances allows us to make informed decisions rather than relying on the allure of novelty.

References

Alves, R., & Grimalt, R. (2016). Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatologic Surgery, 42(4), 491–497. https://pubmed.ncbi.nlm.nih.gov/27035501/

Gentile, P., Garcovich, S., Bielli, A., Scioli, M. G., Orlandi, A., & Cervelli, V. (2015). The effect of platelet-rich plasma in hair regrowth: A randomized placebo-controlled trial. Stem Cells Translational Medicine, 4(11), 1317–1323. https://pubmed.ncbi.nlm.nih.gov/26400925/

Gupta, A. K., & Carviel, J. L. (2017). Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia. Journal of Dermatological Treatment, 28(1), 55–58. https://pubmed.ncbi.nlm.nih.gov/27152474/

Paichitrojjana, A., & Paichitrojjana, A. (2022). Platelet rich plasma and its use in hair regrowth: A review. Drug Design, Development and Therapy, 16, 635–645. https://pubmed.ncbi.nlm.nih.gov/35300222/

Zhang, X., Ji, Y., Zhou, M., et al. (2023). Platelet-rich plasma for androgenetic alopecia: A systematic review and meta-analysis of randomized controlled trials. Journal of Cutaneous Medicine and Surgery, 27(5), 504–508. https://pubmed.ncbi.nlm.nih.gov/37533146/